Holders — by stockHoldings — by fund
Paradigm Biocapital Advisors LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001855655
$5.34B
disclosed book value
28
positions
22.3%
largest position share
Positions, as of 2026-06-30
top 28 of 28 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 6.4M | $1.19B | 22.3% |
| 2 | NUVALENT INC | 5.9M | $731.7M | 13.7% |
| 3 | EWTXEDGEWISE THERAPEUTICS INC | 10.2M | $415.1M | 7.8% |
| 4 | GMABGENMAB A/S | 13.1M | $360.8M | 6.8% |
| 5 | SYRESPYRE THERAPEUTICS INC | 3.8M | $341.0M | 6.4% |
| 6 | APGEAPOGEE THERAPEUTICS INC | 1.6M | $209.2M | 3.9% |
| 7 | ORKAORUKA THERAPEUTICS INC | 2.1M | $204.1M | 3.8% |
| 8 | TNGXTANGO THERAPEUTICS INC | 6.4M | $198.7M | 3.7% |
| 9 | BLTEBELITE BIO INC | 1.2M | $189.8M | 3.6% |
| 10 | ERASERASCA INC | 9.6M | $175.0M | 3.3% |
| 11 | TARSTARSUS PHARMACEUTICALS INC | 2.8M | $174.7M | 3.3% |
| 12 | ALNYALNYLAM PHARMACEUTICALS INC | 480,000 | $144.5M | 2.7% |
| 13 | INSMINSMED INC | 1.3M | $141.4M | 2.6% |
| 14 | MBXMBX BIOSCIENCES INC | 2.5M | $138.4M | 2.6% |
| 15 | PCVXVAXCYTE INC | 2.1M | $123.7M | 2.3% |
| 16 | VRDNVIRIDIAN THERAPEUTICS INC | 6.7M | $123.5M | 2.3% |
| 17 | OLMAOLEMA PHARMACEUTICALS INC | 8.7M | $108.5M | 2% |
| 18 | JBIOJADE BIOSCIENCES INC | 2.9M | $63.5M | 1.2% |
| 19 | TYRATYRA BIOSCIENCES INC | 1.8M | $58.4M | 1.1% |
| 20 | ASMBASSEMBLY BIOSCIENCES INC | 1.6M | $42.7M | 0.8% |
| 21 | EYPTEYEPOINT INC | 2.9M | $41.3M | 0.8% |
| 22 | ACHVACHIEVE LIFE SCIENCE INC | 5.0M | $32.3M | 0.6% |
| 23 | VORVOR BIOPHARMA INC | 1.8M | $32.2M | 0.6% |
| 24 | MPLTMAPLIGHT THERAPEUTICS INC | 685,852 | $24.6M | 0.5% |
| 25 | KARDKARDIGAN INC | 900,000 | $21.5M | 0.4% |
| 26 | LXEOLEXEO THERAPEUTICS INC | 4.2M | $19.4M | 0.4% |
| 27 | EDITEDITAS MEDICINE INC | 5.6M | $18.1M | 0.3% |
| 28 | IVAINVENTIVA SA | 4.0M | $15.1M | 0.3% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.